Fintel reports that on January 24, 2025, Piper Sandler upgraded their outlook for Travelers Companies (NYSE:TRV) from Neutral ...

Insurance company The Travelers Companies (NYSE:TRV) was upgraded at Piper Sandler after stronger-than-expected Q4 results, ...

Piper Sandler reiterated an Overweight rating and $670 price target on Meta Platforms (META) after CEO Mark Zuckerberg said in a Facebook post ...

Fintel reports that on January 23, 2025, Piper Sandler initiated coverage of Bright Minds Biosciences (NasdaqCM:DRUG) with a ...

Piper Sandler raised the firm’s price target on PayPal (PYPL) to $93 from $88 and keeps a Neutral rating on the shares. The firm believes that ...

Salesforce shows potential for growth with dominant market share and AI-driven interest from Agentforce, according to Piper ...

Tesla remains the “top buy-and-hold” stock for analysts at Piper Sandler, who massively raised their price target for the ...

Shares of Travelers (NYSE: NYSE:TRV) climbed 1% as Piper Sandler shifted its stance on the insurance giant, upgrading the stock from Neutral to Overweight and significantly raising the price target ...

Elon Musk's Tesla could deliver a choppy H1 given tailwinds from Donald Trump's EV policies, uncertainties in deliveries, and gross margin.

NEW YORK (AP) — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 14.59% ...

Intra-Cellular Therapies Inc (ITCI) stock saw a modest uptick, ending the day at $126.5 which represents a slight increase of $0.30 or 0.24% from the prior close of $126.2. The stock opened at $126.64 ...